CannaPharmaRx Inc
OTC:CPMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
CannaPharmaRx Inc
Operating Income
CannaPharmaRx Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CannaPharmaRx Inc
OTC:CPMD
|
Operating Income
-$1.4m
|
CAGR 3-Years
36%
|
CAGR 5-Years
22%
|
CAGR 10-Years
19%
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Operating Income
$2.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Operating Income
-CA$52.8m
|
CAGR 3-Years
57%
|
CAGR 5-Years
42%
|
CAGR 10-Years
-9%
|
|
|
Cronos Group Inc
TSX:CRON
|
Operating Income
-$14.6m
|
CAGR 3-Years
48%
|
CAGR 5-Years
39%
|
CAGR 10-Years
-23%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Operating Income
-$151.2m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-123%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Operating Income
CA$5.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CannaPharmaRx Inc
Glance View
CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The principal activity of the Company is to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. The firm's activities is centered around projects, such as the Great Northern Project, and the acquisition of Ramon Road Production Campus LLC. The firm is focused on producing wholesale cannabis and hemp for the medical market.
See Also
What is CannaPharmaRx Inc's Operating Income?
Operating Income
-1.4m
USD
Based on the financial report for Dec 31, 2025, CannaPharmaRx Inc's Operating Income amounts to -1.4m USD.
What is CannaPharmaRx Inc's Operating Income growth rate?
Operating Income CAGR 10Y
19%
Over the last year, the Operating Income growth was 21%. The average annual Operating Income growth rates for CannaPharmaRx Inc have been 36% over the past three years , 22% over the past five years , and 19% over the past ten years .
